361437-00-5

Basic information

• Product Name: 4-(4-Fluorophenoxy)phenylboronic acid
• Synonyms: 4-(4-Fluorophenoxy)phenylboronic acid;Boronic acid,B-[4-(4-fluorophenoxy)phenyl]-
• CAS NO: 361437-00-5
• Molecular Formula: C₁₂H₁₀BFO₃
• Molecular Weight: 232.0154032
• Mol File: 361437-00-5.mol

Chemical Properties

• Boiling Point: 374℃
• Flash Point: 180℃
• Appearance: /
• Density: 1.30
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 4-(4-Fluorophenoxy)phenylboronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-Fluorophenoxy)phenylboronic acid(361437-00-5)
• EPA Substance Registry System: 4-(4-Fluorophenoxy)phenylboronic acid(361437-00-5)

Safety Data

• Hazardous Substances Data: 361437-00-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-(4-Fluorophenoxy)phenylboronic acid is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to participate in Suzuki-Miyaura cross-coupling reactions. These reactions facilitate the formation of carbon-carbon bonds, which are essential for constructing complex molecular structures found in many drugs.
Used in Organic Synthesis:
In the field of organic synthesis, 4-(4-Fluorophenoxy)phenylboronic acid is employed as a reagent for the preparation of biologically active compounds. Its reactivity in cross-coupling reactions allows for the creation of diverse molecular structures with potential applications in medicine and other fields.
Used in OLED Manufacturing:
4-(4-Fluorophenoxy)phenylboronic acid is used as a precursor material in the production of organic light-emitting diodes (OLEDs). Its incorporation into the OLED structure can influence the device's performance, such as brightness, efficiency, and color characteristics, making it a valuable component in the development of advanced display technologies.

Upstream product

• 55102-99-3 1-bromo-4-(4-fluorophenoxy) benzene 
• 5419-55-6 Triisopropyl borate 
• 73183-34-3 bis(pinacol)diborane 
• 330-84-7 4-fluorophenoxybenzene 
• 589-87-7 1,4-bromoiodobenzene 
• 371-41-5 4-Fluorophenol 

Downstream Products

• 1371595-84-4 (S)-2-{4-[4-(4-fluoro-phenoxy)-phenyl]-quinazolin-2-ylamino}-3-hydroxy-propionamide 
• 1371596-32-5 C₂₂H₁₅FN₂O 
• 1371596-31-4 C₂₀H₁₂ClFN₂O 
• 1027188-57-3 5-(tert-butyl-dimethyl-silanyloxymethyl)-3-[4-(4-fluoro-phenoxy)-phenyl]-2-oxo-2,5-dihydro-pyrrole-1-carboxylic acid tert-butyl ester 
• 1354200-00-2 6-(4-(4-fluorophenoxy)phenyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one 
• 1127563-71-6 6-(4-(4-fluorophenoxy)phenyl)-4-chloropyridine-2-carbonitrile 
• 1578241-99-2 4-chloro-2-[4-(4-fluorophenoxy)phenyl]pyridine 
• 1578242-00-8 4-chloro-3-[4-(4-fluorophenoxy)phenyl]pyridine 

Relevant articles and documents

CYCLIC MOLECULES AS BRUTON'S TYROSINE KINASE INHIBITOR

The present invention relates to a novel molecule with protein tyrosine kinase inhibitory activity, and the synthesis and usage thereof. Specifically, the present invention relates to compound by formula A, pharmaceutically acceptable salts, hydrates or solvates thereof, and the synthesis and usage thereof.

Pyrazolopyrimidine derivative, preparation method, pharmaceutical composition and application

The invention discloses a pyrazolopyrimidine derivative, a preparation method, a pharmaceutical composition and application. The invention provides the pyrazolopyrimidine derivative as shown in a formula I and stereoisomer or solvate or pharmaceutically acceptable salts or active metabolite or prodrug thereof. The pyrazolopyrimidine derivative as shown in the formula I has good inhibitory activity on Bruton's tyrosine kinase (Btk) and particularly has good in vitro and in vivo inhibitory activity on growth of tumor cells, and a good marketization prospect is achieved. Please see the formula I in the description.

Platinum(II) cyclometallates featuring broad emission bands and their applications in color-tunable OLEDs and high color-rendering WOLEDs

Two phosphorescent platinum(ii) cyclometallated complexes with phenoxy groups (1 and 2) have been developed. The modified organic ligands derived by combining the phenoxy moiety and 2-phenylpyridine conferred them with a more flexible structure, leading to superior intermolecular interaction properties of the resulting Pt(ii) metallophosphors. Because of the excimer formation induced by Pt(ii) complexes 1 and 2, the emission color can be tuned over a wide range from cyan to orange by simply increasing the concentration of the Pt(ii) metallophosphors. Inspired by their broad emission band, color tunability and outstanding electroluminescence (EL) performance, these two Pt(ii) phosphors complemented with blue fluorescent emitter 4,4′-bis(9-ethyl-3-carbazovinylene)-1,1′-biphenyl (BCzVBi) were employed in manufacturing high color-rendering white organic light-emitting devices (WOLEDs). In such simple two-emitter systems, 1-based WOLEDs exhibited reasonable EL performance with an external quantum efficiency (ηext) of 11.7%, luminance efficiency (ηL) of 29.1 cd A-1, power efficiency (ηp) of 16.9 lm W-1 and color rendering index (CRI) of 77, whereas 2-based WOLEDs demonstrated an ηext of 10%, ηL of 21.7 cd A-1, ηp of 10.7 lm W-1 and CRI of 88.

INHIBITORS OF FATTY ACID AMIDE HYDROLASE

The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). The present invention also provides methods for treating FAAH mediated disease, disorder or condition by administering a ther